Protai combines proteomics and machine learning to simulate disease on the molecular level. The company leverages mass spectrometry derived proteomics data and other protein-oriented large-scale datasets to model biological processes.

Eran Seger

Kirill Pevzner

Protai

Protai has built an end-to-end AI-based platform that comprehensively maps the course of disease on the protein level, enhancing the ability to observe cellular function and improve the way new drugs are discovered.

Pitango VC

Grove Ventures

Maj Invest Equity

🌟 Protai at #ESMO24! 🌟 
We are thrilled to announce that at the upcoming ESMO Congress, Protai will be presenting multiple groundbreaking results from our AIMS discovery platform. 

Here's what to look forward to:
1️⃣ A large scale proteogenomics atlas for precision oncology research. Sunday 15th September, Poster area of Hall 6
2️⃣ Integrative Proteomic Profiling in High-Grade Serous Ovarian Carcinoma: Unraveling Biomarkers and Therapeutic Targets. Sunday 15th September, Poster area of Hall 6

Don’t miss out on these exciting developments! For full details and to schedule a meeting with our team, please contact us at: Contact@protai.bio. 
Eran Seger | Kirill Pevzner | Gali Arad | Nitzan Simchi | Anjana Shenoy
#ESMO2024 #AI #Proteomics #PrecisionOncology #Innovation

Protai is honored to be featured in TheMarker’s esteemed list of the 20 most promising Israeli startups for 2024. 

Another testament to our team’s dedication and hard work. 

https://lnkd.in/d4zYMyew

Ruti Levy  #themarker #Prize #2024 #Protai #team #Innovation
Kirill Pevzner, Eran Seger

We are thrilled to welcome Sagie Brodsky, PhD to our Translational Biology team as a Systems Biologist! 🚀 

Sagie joins us with valuable experience from the Barkai Lab at the Weizmann Institute of Science and we can’t wait to see the incredible contributions he will make to our mission.

Welcome aboard, Sagie! 

We’re glad to have you on the team!

#Protai #Team #Proteomics #AI #SystemsBiology

Protai has a new pipeline page 💊 with several programs rapidly progressing towards the clinic. Representing Protai dual R&D effort for biomarker and drug discovery. 

#Proteomics #AI #PrecisionMedicine  

https://lnkd.in/dm74BrUJ

Our own Nitzan Simchi writes about proteomics dataset harmonization, which powers our clinical proteomics atlas

Michal Ran Shchory - Welcome to Protai! 

We are delighted to welcome Michal Ran Shchory to the SW & Algo team!
Michal brings with her extensive experience from her technological and management roles in the Intelligence Corps of the IDf.

She holds a B.Sc. in Engineering and Physics, as well as a Master's degree in Biomedical Engineering. Notably, Michal's favorite protein is pea protein, a vital component in alternative meats. 

Welcome to Protai, Michal!

#Protai #team #bioinformatics #proteomics #ai

Protai is celebrating its 3rd anniversary, marking three successful years of pioneering Proteomics & AI driven drug discovery.

2 cutting-edge drug programs are making rapid progress towards the clinic, with several others on the way.

Our brand new lab signifies a pivotal moment as we unite our computational and biological teams under one roof, fostering seamless collaboration and innovation.

Great collaborations with top biotech and scientific institutions worldwide are driving impactful outcomes.

I'm inspired by the incredible team that has joined our journey - together, we're ready to achieve remarkable things.

Kirill Pevzner, Tami Geiger, Sharon Shacham, Giulio Draetta, Gali Arad, Nitzan Simchi, Anjana Shenoy, Lior Handelsman, Ittai Harel

#Protai #anniversary #proteomics #ai #drugdiscovery #Teamwork

Protai will be attending BIO International in San Diego.
Meet our team to hear more about our AI Proteomics drug discovery platform.
 
#bio24 #protai 
#proteomics #ai 
Eran Seger | Kirill Pevzner

Meet us at #ASCO

Meet Protai at ASCO to learn about our precision oncology pipeline and unique proteomics & AI platform for biomarkers and drug discovery.

#ASCO24 #protai #proteomics #AI 


Kirill Pevzner | Eran Seger

Come to hear about Precision medicine at Protai from Eran Seger, our CEO and co-founder, and learn about how the OrganoSphere initiative is going tp impact the Israeli industry. 

Irit Carmi-Levy | Eran Seger 

#PrecisionMedicine #Protai #OrganoSphere #HealthcareInnovation

Metric
Company Name	Protai
Symbol
MSH ID	BIO:PROTAI
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	US
Stage
Employee Count	11
Website	protai.bio
LinkedIn	protai-bio
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

PROT

BIO:PROTAI

Protai

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue